October 20, 2021 -- Viome Life Sciences has expanded its partnership with GlaxoSmithKline (GSK) to develop potential therapies for cancer and autoimmune diseases.
Through the collaboration, Viome and GSK will examine the connection between the gut microbiome and the onset of specific chronic disorders. The companies will explore therapies using targets based on Viome's discovery platform, which analyzes host and microbial interaction at the onset and progression of diseases.